Subscribe To
Avalon globocare expands its cellular immuno-oncology program with addition of chimeric antigen receptor-natural killer cell therapies
Avalon GloboCare Corp (NASDAQ:AVCO) said it is expanding its cellular immuno-oncology program with the ...
February 14, 2022, 10:21 am
Intra-cellular therapies to present at the 11th annual svb leerink global healthcare conference
NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmac...
February 10, 2022, 8:00 am
Intra-cellular therapies to present at the 11th annual svb leerink global healthcare conference
NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmac...
February 10, 2022, 8:00 am
Intra-cellular therapies to present at the 11th annual svb leerink global healthcare conference
NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmac...
February 10, 2022, 8:00 am
Humacyte posts preclinical data of small-diameter human acellular vessel in bypass grafting
Humacyte Inc HUMA has announced results from the first preclinical study of Humacyte's small-diameter (3.5mm) Human Acel...
January 28, 2022, 12:25 pm
Humacyte posts preclinical data of small-diameter human acellular vessel in bypass grafting
Humacyte Inc HUMA has announced results from the first preclinical study of Humacyte's small-diameter (3.5mm) Human Acel...
January 28, 2022, 12:25 pm
Humacyte posts preclinical data of small-diameter human acellular vessel in bypass grafting
Humacyte Inc HUMA has announced results from the first preclinical study of Humacyte's small-diameter (3.5mm) Human Acel...
January 28, 2022, 12:25 pm
Mccormick ceo discusses the growth of cholula hot sauce and at-home cooking trends
Lawrence Kurzius, chairman, president and CEO of McCormick, appeared on Thursday's episode of "Mad Money."...
January 27, 2022, 8:23 pm
Mccormick ceo discusses the growth of cholula hot sauce and at-home cooking trends
Lawrence Kurzius, chairman, president and CEO of McCormick, appeared on Thursday's episode of "Mad Money."...
January 27, 2022, 8:23 pm
Mccormick ceo discusses the growth of cholula hot sauce and at-home cooking trends
Lawrence Kurzius, chairman, president and CEO of McCormick, appeared on Thursday's episode of "Mad Money."...
January 27, 2022, 8:23 pm
Mesoblast to participate in edison group's global healthcare “open house” virtual conference from january 25-27th, 2022
NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cel...
January 24, 2022, 6:45 pm
Mesoblast to participate in edison group's global healthcare “open house” virtual conference from january 25-27th, 2022
NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cel...
January 24, 2022, 6:45 pm
Mesoblast to participate in edison group's global healthcare “open house” virtual conference from january 25-27th, 2022
NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cel...
January 24, 2022, 6:45 pm
Things to keep in mind before mccormick's (mkc) q4 earnings
McCormick's (MKC) fourth-quarter fiscal 2021 performance is likely to reflect benefits from recovery in foodservice demand. Also, gains from FONA and ...
January 24, 2022, 10:49 am
Things to keep in mind before mccormick's (mkc) q4 earnings
McCormick's (MKC) fourth-quarter fiscal 2021 performance is likely to reflect benefits from recovery in foodservice demand. Also, gains from FONA and ...
January 24, 2022, 10:49 am
Things to keep in mind before mccormick's (mkc) q4 earnings
McCormick's (MKC) fourth-quarter fiscal 2021 performance is likely to reflect benefits from recovery in foodservice demand. Also, gains from FONA and ...
January 24, 2022, 10:49 am
Strength seen in intra-cellular (itci): can its 9.8% jump turn into more strength?
Intra-Cellular (ITCI) witnessed a jump in share price last session on above-average trading volume. The...
January 24, 2022, 4:40 am
Strength seen in intra-cellular (itci): can its 9.8% jump turn into more strength?
Intra-Cellular (ITCI) witnessed a jump in share price last session on above-average trading volume. The...
January 24, 2022, 4:40 am
Strength seen in intra-cellular (itci): can its 9.8% jump turn into more strength?
Intra-Cellular (ITCI) witnessed a jump in share price last session on above-average trading volume. The...
January 24, 2022, 4:40 am
Astrazeneca rolls out "unprecedented' three year survival data for imfinzi/treme combo in liver cancer
A combination of tremelimumab and AstraZeneca Plc's (NASDAQ: AZN) Imfinzi (durvalumab) extended the lives of newly diagnosed patients with unresec...
January 19, 2022, 12:50 pm